No Data
No Data
FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides
Express News | Trading Halt: Halt Status Updated at 8:00:00 AM ET: Quotation Resumption: News and Resumption Times
Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI (Marnetegragene Autotemcel; Marne-cel)
Express News | Trading Halt: Halted at 6:56:37 A.m. ET - Trading Halt: Halt News Pending
Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans
Rocket Pharmaceuticals Presents Positive Data From LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
No Data